Title: Multidimensional extracellular-matrix analysis reveals a silent pre-clinical signature in inflammatory disease
暂无分享,去创建一个
U. Alon | P. Milani | C. Luchinat | T. Geiger | P. Turano | N. Gluck | V. Ghini | S. Fishman | A. Podestà | D. Shouval | I. Sagi | Miri Adler | C. Varol | L. Werner | L. Puricelli | R. Afik | E. Shimshoni | Anjana Shenoy | Odelia Mouhadeb
[1] Jean-Luc Pellequer,et al. Standardized Nanomechanical Atomic Force Microscopy Procedure (SNAP) for Measuring Soft and Biological Samples , 2017, Scientific Reports.
[2] Judy H. Cho,et al. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study , 2017, The Lancet.
[3] Jüergen Cox,et al. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.
[4] Z. Halpern,et al. Tumor macrophages are pivotal constructors of tumor collagenous matrix , 2016, The Journal of experimental medicine.
[5] I. Amit,et al. Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality. , 2016, Cell host & microbe.
[6] Irit Sagi,et al. Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix. , 2016, Cancer research.
[7] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[8] M. Bøgsted,et al. Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies , 2015, Inflammatory bowel diseases.
[9] I. Dotan,et al. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation , 2014, Gut.
[10] G. Rogler,et al. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. , 2014, Journal of Crohn's & colitis.
[11] P. Milani,et al. Nanomechanical and topographical imaging of living cells by atomic force microscopy with colloidal probes. , 2014, The Review of scientific instruments.
[12] Marco Y. Hein,et al. Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.
[13] R. Khokha,et al. Metalloproteinases and their natural inhibitors in inflammation and immunity , 2013, Nature Reviews Immunology.
[14] Christophe Ley,et al. Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median , 2013 .
[15] R. Goldberg,et al. Versatile role of heparanase in inflammation. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[16] R. Iozzo,et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation , 2013, The FEBS journal.
[17] B. Fingleton,et al. Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia , 2012, Laboratory Investigation.
[18] N. Kawazoe,et al. Comparison of decellularization techniques for preparation of extracellular matrix scaffolds derived from three-dimensional cell culture. , 2012, Journal of biomedical materials research. Part A.
[19] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[20] M. Elkin,et al. Heparanase enzyme in chronic inflammatory bowel disease and colon cancer , 2012, Cellular and Molecular Life Sciences.
[21] D. Huso,et al. Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis , 2012, Inflammatory bowel diseases.
[22] Steven A. Carr,et al. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices , 2011, Molecular & Cellular Proteomics.
[23] M. Krzystek-Korpacka,et al. Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children , 2011, Digestive Diseases and Sciences.
[24] C. Motte. Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis. , 2011 .
[25] P. Milani,et al. Adhesive-free colloidal probes for nanoscale force measurements: production and characterization. , 2011, The Review of scientific instruments.
[26] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[27] Valerie M. Weaver,et al. The extracellular matrix at a glance , 2010, Journal of Cell Science.
[28] L. Sorokin. The impact of the extracellular matrix on inflammation , 2010, Nature Reviews Immunology.
[29] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[30] Richard O. Hynes,et al. The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.
[31] C. Fiocchi,et al. Intestinal fibrosis in IBD—a dynamic, multifactorial process , 2009, Nature Reviews Gastroenterology &Hepatology.
[32] T. Kirkegaard,et al. Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium , 2009, Clinical and experimental immunology.
[33] G. Rogler,et al. Diagnosis and management of fistulizing Crohn's disease , 2009, Nature Clinical Practice Gastroenterology &Hepatology.
[34] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[35] J. Keski‐Oja,et al. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. , 2008, Experimental cell research.
[36] C. A. de la Motte,et al. Hyaluronan (HA) Deposition Precedes and Promotes Leukocyte Recruitment in Intestinal Inflammation , 2008, Clinical and translational science.
[37] B F Warren,et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. , 2008, Journal of Crohn's & colitis.
[38] N. Vij,et al. A Novel Role of the Lumican Core Protein in Bacterial Lipopolysaccharide-induced Innate Immune Response* , 2007, Journal of Biological Chemistry.
[39] H. Verspaget,et al. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[40] M. Neurath,et al. High resolution colonoscopy in live mice , 2006, Nature Protocols.
[41] B F Warren,et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis , 2006, Gut.
[42] M. Rojas,et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. , 2005, Gastroenterology.
[43] H. Butt,et al. Force measurements with the atomic force microscope: Technique, interpretation and applications , 2005 .
[44] A. Marneros,et al. Physiological role of collagen XVIII and endostatin , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] T. Macdonald,et al. Matrix metalloproteinases and the gut - new roles for old enzymes. , 2004, Current opinion in pharmacology.
[46] Z. Werb,et al. Regulation of matrix biology by matrix metalloproteinases. , 2004, Current opinion in cell biology.
[47] R. Kauppinen,et al. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. , 2004, Human molecular genetics.
[48] T. Kirkegaard,et al. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn’s disease , 2004, Gut.
[49] M. Karjalainen‐Lindsberg,et al. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing , 2004, Scandinavian journal of gastroenterology.
[50] J. Keski‐Oja,et al. Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation , 2004 .
[51] Ivan Stamenkovic,et al. Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.
[52] Juan Zhang,et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. , 2002, Gastroenterology.
[53] Takanori Aoki,et al. Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165* , 2002, The Journal of Biological Chemistry.
[54] Pauline M. Rudd,et al. Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9) , 2002, Critical reviews in biochemistry and molecular biology.
[55] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[56] P. E. Van den Steen,et al. Gelatinase B: a tuner and amplifier of immune functions. , 2001, Trends in immunology.
[57] C. J. Taylor,et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. , 1999, Gastroenterology.
[58] J. Guillem,et al. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. , 1999, Carcinogenesis.
[59] C. Martínez-A,et al. The Matrix Metalloproteinase-9 Regulates the Insulin-like Growth Factor-triggered Autocrine Response in DU-145 Carcinoma Cells* , 1999, The Journal of Biological Chemistry.
[60] John M. Whitelock,et al. The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases (*) , 1996, The Journal of Biological Chemistry.
[61] C. Bailey,et al. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. , 1994, Journal of clinical pathology.
[62] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[63] M. E. van der Rest,et al. Collagen family of proteins , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] Ada Hamosh,et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.
[65] R. Pyeritz,et al. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. , 1990, The New England journal of medicine.
[66] E. Engvall,et al. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils , 1986, The Journal of cell biology.
[67] S. Udenfriend. Formation of Hydroxyproline in Collagen , 1966, Science.
[68] I. Sagi,et al. Sample Preparation of Extracellular Matrix of Murine Colons for Scanning Electron Microscopy. , 2019, Methods in molecular biology.
[69] C. Fiocchi,et al. Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.
[70] R. Panush. Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential , 2012 .
[71] Jason L Johnson,et al. In situ zymography. , 2010, Methods in molecular biology.
[72] R. Eliakim,et al. Heparanase upregulation by colonic epithelium in inflammatory bowel disease , 2007, Modern Pathology.
[73] Alberto Maria Segre,et al. Programs for Machine Learning , 1994 .
[74] T. Ohkusa,et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. , 1990, Gastroenterology.
[75] H. Cramér. Mathematical methods of statistics , 1946 .